156 related articles for article (PubMed ID: 26064463)
1. Survival in an incident cohort of patients with pulmonary arterial hypertension in Denmark.
Korsholm K; Andersen A; Kirkfeldt RE; Hansen KN; Mellemkjær S; Nielsen-Kudsk JE
Pulm Circ; 2015 Jun; 5(2):364-9. PubMed ID: 26064463
[TBL] [Abstract][Full Text] [Related]
2. Real-world, long-term survival of incident patients with pulmonary arterial hypertension.
Marques-Alves P; Baptista R; Marinho da Silva A; Pêgo M; Castro G
Rev Port Pneumol (2006); 2017; 23(3):124-131. PubMed ID: 28283462
[TBL] [Abstract][Full Text] [Related]
3. Epidemiology and long-term survival of pulmonary arterial hypertension in the Czech Republic: a retrospective analysis of a nationwide registry.
Jansa P; Jarkovsky J; Al-Hiti H; Popelova J; Ambroz D; Zatocil T; Votavova R; Polacek P; Maresova J; Aschermann M; Brabec P; Dusek L; Linhart A
BMC Pulm Med; 2014 Mar; 14():45. PubMed ID: 24629043
[TBL] [Abstract][Full Text] [Related]
4. Survival of Idiopathic Pulmonary Arterial Hypertension Patients in the Modern Era in Australia and New Zealand.
Strange G; Lau EM; Giannoulatou E; Corrigan C; Kotlyar E; Kermeen F; Williams T; Celermajer DS; Dwyer N; Whitford H; Wrobel JP; Feenstra J; Lavender M; Whyte K; Collins N; Steele P; Proudman S; Thakkar V; Keating D; Keogh A;
Heart Lung Circ; 2018 Nov; 27(11):1368-1375. PubMed ID: 29029950
[TBL] [Abstract][Full Text] [Related]
5. [Risk factors for death and the clinical features of different subtypes of patients with pulmonary arterial hypertension related to congenital heart disease].
Xu ZY; Li QQ; Zhang C; Zhang HS; Gu H
Zhonghua Xin Xue Guan Bing Za Zhi; 2020 Apr; 48(4):315-322. PubMed ID: 32370483
[No Abstract] [Full Text] [Related]
6. Baseline Characteristics of the Korean Registry of Pulmonary Arterial Hypertension.
Chung WJ; Park YB; Jeon CH; Jung JW; Ko KP; Choi SJ; Seo HS; Lee JS; Jung HO;
J Korean Med Sci; 2015 Oct; 30(10):1429-38. PubMed ID: 26425039
[TBL] [Abstract][Full Text] [Related]
7. Pulmonary Hypertension in Adults with Congenital Heart Disease: Real-World Data from the International COMPERA-CHD Registry.
Kaemmerer H; Gorenflo M; Huscher D; Pittrow D; Apitz C; Baumgartner H; Berger F; Bruch L; Brunnemer E; Budts W; Claussen M; Coghlan G; Dähnert I; D'Alto M; Delcroix M; Distler O; Dittrich S; Dumitrescu D; Ewert R; Faehling M; Germund I; Ghofrani HA; Grohé C; Grossekreymborg K; Halank M; Hansmann G; Harzheim D; Nemes A; Havasi K; Held M; Hoeper MM; Hofbeck M; Hohenfrost-Schmidt W; Jurevičienė E; Gumbienè L; Kabitz HJ; Klose H; Köhler T; Konstantinides S; Köestenberger M; Kozlik-Feldmann R; Kramer HH; Kropf-Sanchen C; Lammers A; Lange T; Meyn P; Miera O; Milger-Kneidinger K; Neidenbach R; Neurohr C; Opitz C; Perings C; Remppis BA; Riemekasten G; Scelsi L; Scholtz W; Simkova I; Skowasch D; Skride A; Stähler G; Stiller B; Tsangaris I; Vizza CD; Vonk Noordegraaf A; Wilkens H; Wirtz H; Diller GP; Grünig E; Rosenkranz S
J Clin Med; 2020 May; 9(5):. PubMed ID: 32414075
[TBL] [Abstract][Full Text] [Related]
8. Prognostic Value of Follow-Up Hemodynamic Variables After Initial Management in Pulmonary Arterial Hypertension.
Weatherald J; Boucly A; Chemla D; Savale L; Peng M; Jevnikar M; Jaïs X; Taniguchi Y; O'Connell C; Parent F; Sattler C; Hervé P; Simonneau G; Montani D; Humbert M; Adir Y; Sitbon O
Circulation; 2018 Feb; 137(7):693-704. PubMed ID: 29070502
[TBL] [Abstract][Full Text] [Related]
9. Survival in patients with idiopathic, familial, and anorexigen-associated pulmonary arterial hypertension in the modern management era.
Humbert M; Sitbon O; Chaouat A; Bertocchi M; Habib G; Gressin V; Yaïci A; Weitzenblum E; Cordier JF; Chabot F; Dromer C; Pison C; Reynaud-Gaubert M; Haloun A; Laurent M; Hachulla E; Cottin V; Degano B; Jaïs X; Montani D; Souza R; Simonneau G
Circulation; 2010 Jul; 122(2):156-63. PubMed ID: 20585011
[TBL] [Abstract][Full Text] [Related]
10. Functional class improvement and 3-year survival outcomes in patients with pulmonary arterial hypertension in the REVEAL Registry.
Barst RJ; Chung L; Zamanian RT; Turner M; McGoon MD
Chest; 2013 Jul; 144(1):160-168. PubMed ID: 23429998
[TBL] [Abstract][Full Text] [Related]
11. Analysis of pulmonary hypertension patient survival after treatment in referral center (data of first Ukrainian register).
Radchenko GD; Zhyvylo IO; Sirenko YM
Pulm Circ; 2019; 9(2):2045894019845604. PubMed ID: 30942126
[TBL] [Abstract][Full Text] [Related]
12. Pulmonary Arterial Hypertension Associated With Systemic Lupus Erythematosus: Results From the French Pulmonary Hypertension Registry.
Hachulla E; Jais X; Cinquetti G; Clerson P; Rottat L; Launay D; Cottin V; Habib G; Prevot G; Chabanne C; Foïs E; Amoura Z; Mouthon L; Le Guern V; Montani D; Simonneau G; Humbert M; Sobanski V; Sitbon O;
Chest; 2018 Jan; 153(1):143-151. PubMed ID: 28851621
[TBL] [Abstract][Full Text] [Related]
13. Long-Term Outcomes in Systemic Sclerosis-Associated Pulmonary Arterial Hypertension From the Pulmonary Hypertension Assessment and Recognition of Outcomes in Scleroderma Registry (PHAROS).
Kolstad KD; Li S; Steen V; Chung L;
Chest; 2018 Oct; 154(4):862-871. PubMed ID: 29777655
[TBL] [Abstract][Full Text] [Related]
14. Pulmonary arterial hypertension in a multi-ethnic Asian population: Characteristics, survival and mortality predictors from a 14-year follow-up study.
Lim Y; Low TT; Chan SP; Teo TW; Jang JJ; Yip N; Kuntjoro I; Tay EL; Yip JW
Respirology; 2019 Feb; 24(2):162-170. PubMed ID: 30180305
[TBL] [Abstract][Full Text] [Related]
15. Anticoagulation and survival in pulmonary arterial hypertension: results from the Comparative, Prospective Registry of Newly Initiated Therapies for Pulmonary Hypertension (COMPERA).
Olsson KM; Delcroix M; Ghofrani HA; Tiede H; Huscher D; Speich R; Grünig E; Staehler G; Rosenkranz S; Halank M; Held M; Lange TJ; Behr J; Klose H; Claussen M; Ewert R; Opitz CF; Vizza CD; Scelsi L; Vonk-Noordegraaf A; Kaemmerer H; Gibbs JS; Coghlan G; Pepke-Zaba J; Schulz U; Gorenflo M; Pittrow D; Hoeper MM
Circulation; 2014 Jan; 129(1):57-65. PubMed ID: 24081973
[TBL] [Abstract][Full Text] [Related]
16. Pulmonary arterial hypertension in Russia: six-year observation analysis of the National Registry.
Chazova IE; Arkhipova OA; Martynyuk TV
Ter Arkh; 2019 Mar; 91(1):24-31. PubMed ID: 31090367
[TBL] [Abstract][Full Text] [Related]
17. Four- and seven-year outcomes of patients with congenital heart disease-associated pulmonary arterial hypertension (from the REVEAL Registry).
Barst RJ; Ivy DD; Foreman AJ; McGoon MD; Rosenzweig EB
Am J Cardiol; 2014 Jan; 113(1):147-55. PubMed ID: 24176071
[TBL] [Abstract][Full Text] [Related]
18. An evaluation of long-term survival from time of diagnosis in pulmonary arterial hypertension from the REVEAL Registry.
Benza RL; Miller DP; Barst RJ; Badesch DB; Frost AE; McGoon MD
Chest; 2012 Aug; 142(2):448-456. PubMed ID: 22281797
[TBL] [Abstract][Full Text] [Related]
19. Current era survival of patients with pulmonary arterial hypertension associated with congenital heart disease: a comparison between clinical subgroups.
Manes A; Palazzini M; Leci E; Bacchi Reggiani ML; Branzi A; Galiè N
Eur Heart J; 2014 Mar; 35(11):716-24. PubMed ID: 23455361
[TBL] [Abstract][Full Text] [Related]
20. Pulmonary arterial hypertension in the southern hemisphere: results from a registry of incident Brazilian cases.
Alves JL; Gavilanes F; Jardim C; Fernandes CJCDS; Morinaga LTK; Dias B; Hoette S; Humbert M; Souza R
Chest; 2015 Feb; 147(2):495-501. PubMed ID: 25317567
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
